نتایج جستجو برای: amacr protein

تعداد نتایج: 1234789  

2016
Imane Abdellaoui Maane Hicham El Hadi Zineb Qmichou Abderrahmane Al Bouzidi Youssef Bakri Hassan Sefrioui Nadia Dakka Abdeladim Moumen

Prostate cancer (PCa) remains one of the most widespread and perplexing of all human malignancies. Assessment of gene expression is thought to have an important impact on cancer diagnosis, prognosis and therapeutic decisions. In this context, we explored combined expression of PCa related target genes AMACR and PCA3 in 126 formalin fixed paraffin embedded prostate tissues (FFPE) from Moroccan p...

2016
Mohamadreza Nowroozi Mohsen Ayati Erfan Amini Reza Mahdian Behzad Yousefi Amir Arbab Mansour Jamali Zawarei Hasan Niroomand Hamidreza Ghorbani Alireza Ghadian

OBJECTIVES Prostate cancer is a neoplasm with a variable natural history and clinical behavior. There is much debate on the use of inherited genetic information in clinical application including risk assessment and treatment decisions. This study was performed to evaluate the relationship between clinical parameters of prostate cancer (PSA, Gleason score, and metastasis) and expression of NKX3....

Background & Objective: Some prostatic lesions contain small suspicious foci for prostatic carcinoma in which the morphological features are equivocal. Two immunohistochemical markers namely, cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR), were evaluated in these lesions for a definitive diagnosis and avoiding misdiagnosis or overdiagnosis of prostatic...

Journal: :Journal of clinical pathology 2003
A J Evans

The diagnosis of prostatic adenocarcinoma remains dependent on the recognition of basic haematoxylin and eosin criteria. The discovery of alpha-methylacyl CoA racemase/P504S (AMACR/P504S) overexpression in prostate cancer represents a triumph of high throughput microarray technology, and is a powerful demonstration of how this methodology can be used to facilitate the rapid development of diagn...

Journal: :nephro-urology monthly 0
mohamadreza nowroozi uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran mohsen ayati uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran erfan amini uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran reza mahdian biotechnology research center, molecular medicine department, pasteur institue of iran, tehran, iran behzad yousefi uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran amir arbab uro-oncology research center (uorc), tehran university of medical sciences, tehran, iran

results a total number of 43 specimens were studied, from which 9 were obtained from patients with metastatic prostate cancer. the expression of five examined genes had no correlation with psa level and gleason score. the expression of amacr decreased in metastatic prostate cancer (p = 0.02). the expression of other genes showed no difference between metastatic and non-metastatic tumors (p > 0....

2016
Woo Jin Oh Arthur Minwoo Chung Jee Soon Kim Ji Heun Han Sung Hoo Hong Ji Yeol Lee Yeong Jin Choi

BACKGROUND The pathologic distinction between high-grade prostate adenocarcinoma (PAC) involving the urinary bladder and high-grade urothelial carcinoma (UC) infiltrating the prostate can be difficult. However, making this distinction is clinically important because of the different treatment modalities for these two entities. METHODS A total of 249 patient cases (PAC, 111 cases; UC, 138 case...

2016
Jun-Hyun Han Yoo-Hun Noh Do-Hee Kim Seok-Soo Byun Sung-Su Kim Soon-Chul Myung

To investigate the potential relationship between sequence variants in the AMACR gene and prostate cancer risk in a Korean study cohort. We evaluated the association between 21 single nucleotide polymorphisms (SNPs) in the AMACR gene and prostate cancer risk as well as clinical characteristics (pathological stage and Gleason score) in Korean men (272 prostate cancer patients and 173 benign pros...

2006
Ximing J. Yang

Since the discovery of alpha-methylacyl CoA racemase (AMACR) in prostate cancer in 2000, there have been a number of publications studying the diagnostic value of this enzyme. Although the role of this enzyme is still unknown, the application of AMACR immunohistochemistry in pathology practice has been increased sharply in the last few years. We are going to review the recent studies of the AMA...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید